Osteopathy in the Cranial Field as a Method to Enhance Brain Injury Recovery: A Preliminary Study
Michelle Dickerson1, Susan Murphy1, Natalie Hyppolite2
1Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, Virginia, USA.
Neurotrauma Reports
|November 7, 2022
Summary
Cranial osteopathic manipulative medicine (cOMM) shows promise in treating traumatic brain injury (TBI). This non-invasive approach reduced anxiety-like behaviors and improved glial pathology in a rat model, suggesting potential for better TBI recovery.
Area of Science:
- Neuroscience
- Pathology
- Integrative Medicine
Background:
- Traumatic brain injury (TBI) presents a growing global health challenge, leading to chronic neurological deficits.
- Current TBI treatments often manage symptoms rather than addressing underlying pathology.
- Novel therapeutic strategies are needed to improve recovery and long-term outcomes after TBI.
Purpose of the Study:
- To investigate the neurobiological effects of cranial osteopathic manipulative medicine (cOMM) on TBI.
- To evaluate cOMM's potential to enhance brain fluid transport and alleviate TBI-induced symptoms.
- To determine if cOMM can mitigate the pathological consequences of TBI.
Main Methods:
- Utilized an in vivo rat model of TBI induced by repeated blast overpressure.
- Administered cOMM treatment 24 hours post-injury.
- Quantified fluorescent tracer clearance to assess brain fluid transport.
- Examined pathological changes in the hippocampus, prefrontal cortex, and motor cortex.
Main Results:
- cOMM treatment significantly attenuated acute and subacute anxiety-like behaviors in TBI rats.
- Post-mortem analysis revealed improvements in glial pathology in cOMM-treated animals compared to controls.
- Evidence suggests cOMM may enhance cerebral fluid dynamics, though not explicitly detailed in results.
Conclusions:
- This study is the first to explore cOMM as a potential treatment for TBI.
- cOMM demonstrates a capacity to improve outcomes following TBI in a pre-clinical model.
- Findings suggest cOMM may offer a non-pharmacological approach to mitigate TBI's neurobiological impact.


